EP0371056A4 - Methods and compositions for mimicking antigenic determinants - Google Patents

Methods and compositions for mimicking antigenic determinants

Info

Publication number
EP0371056A4
EP0371056A4 EP19880906638 EP88906638A EP0371056A4 EP 0371056 A4 EP0371056 A4 EP 0371056A4 EP 19880906638 EP19880906638 EP 19880906638 EP 88906638 A EP88906638 A EP 88906638A EP 0371056 A4 EP0371056 A4 EP 0371056A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
antigenic determinants
mimicking
mimicking antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880906638
Other versions
EP0371056A1 (en
Inventor
Kathy D. Knebel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Publication of EP0371056A1 publication Critical patent/EP0371056A1/en
Publication of EP0371056A4 publication Critical patent/EP0371056A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6873Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19880906638 1987-08-07 1988-07-12 Methods and compositions for mimicking antigenic determinants Withdrawn EP0371056A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8354187A 1987-08-07 1987-08-07
US83541 1987-08-07

Publications (2)

Publication Number Publication Date
EP0371056A1 EP0371056A1 (en) 1990-06-06
EP0371056A4 true EP0371056A4 (en) 1990-12-19

Family

ID=22178998

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880906638 Withdrawn EP0371056A4 (en) 1987-08-07 1988-07-12 Methods and compositions for mimicking antigenic determinants

Country Status (5)

Country Link
EP (1) EP0371056A4 (en)
JP (1) JPH03501161A (en)
NZ (1) NZ225371A (en)
WO (1) WO1989001337A1 (en)
ZA (1) ZA885125B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4536479A (en) * 1983-03-22 1985-08-20 E. I. Du Pont De Nemours And Company Use of anti-idiotype antibodies in immunoassays
IL72924A (en) * 1984-09-12 1988-07-31 I D L International Diagnostic Preparations for use in solid phase immunoassays comprising monoclonal antibodies covalently embedded in their immobilized hybridoma cells
US4590071A (en) * 1984-09-25 1986-05-20 Xoma Corporation Human melanoma specific immunotoxins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents have been disclosed. *
See also references of WO8901337A1 *

Also Published As

Publication number Publication date
ZA885125B (en) 1989-04-26
WO1989001337A1 (en) 1989-02-23
NZ225371A (en) 1990-06-26
EP0371056A1 (en) 1990-06-06
JPH03501161A (en) 1991-03-14

Similar Documents

Publication Publication Date Title
US4687663B1 (en) Dental preparation article and method for storage and delivery thereof
DE3369465D1 (en) Bone-equivalent and method for preparation thereof
DE3377462D1 (en) Improved material and method for dentistry
GB8627416D0 (en) Apparatus for inserting prostheses
EP0309132A3 (en) Packaging method and apparatus
EP0448300A3 (en) Method and composition for coiontophoresis
GB2211160B (en) Packaging method and apparatus
NZ215155A (en) Immunogens and compounds containing antigens and/or antigenic determinants
GB2197291B (en) Packaging method and apparatus
DE3268222D1 (en) Organopolysiloxane photosensitizers and methods for their preparation
DE3373623D1 (en) Pharmaceutical combination composition and associated method
IL88321A0 (en) Sialocylglycerolipids and method for preparing same
DE3370796D1 (en) Alpha-iminodiacetonitriles and methods for their preparation
ZA885125B (en) Methods and compositions for mimicking antigenic determinants
GB2226322B (en) Polymeric compositions and method for preparing them
GB2234255B (en) Methylpolysilanes and method for their preparation
EP0293691A3 (en) Ionomer compositions and method for their preparation
DE3360070D1 (en) 1,10-substituted 10-amino-deca-3,7-diene-nitriles and method for their preparation
GB8817557D0 (en) Antigenic determinants
GB8818340D0 (en) Antigenic determinants
GB8828534D0 (en) Inserter apparatus
ZA837879B (en) Packaging elements and methods
BG43919A1 (en) 2- substituted- 8- acetyloxyquinolines and method for their preparation
GR870821B (en) Permanent hair method
GB8823713D0 (en) Method apparatus & composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900205

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19901102

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: G01N 33/53

17Q First examination report despatched

Effective date: 19920904

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930115